Related Experiment Videos
Infection control of lung function equipment: a practical approach.
A H Kendrick1, D P Johns, J P Leeming
1Department of Respiratory Medicine, Bristol Royal Infirmary, Bristol BS2 8HW, UK. adrian.kendrick@ubht.swest.nhs.uk
Respiratory Medicine
|November 26, 2003
Summary
The risk of patient cross-infection from lung function testing equipment is low. Routine cleaning and disinfection are sufficient for most patients, with extra precautions for infectious or immunocompromised individuals.
Area of Science:
- Pulmonary Medicine
- Infection Control
- Medical Equipment Safety
Background:
- Quantifying the risk of cross-infection via lung function testing equipment is crucial.
- Current evidence suggests elaborate precautions are often unnecessary for most patients.
- Routine cleaning and disinfection protocols are essential for equipment safety.
Purpose of the Study:
- To review the existing evidence on cross-infection risks associated with lung function testing equipment.
- To provide practical recommendations for managing infection control in pulmonary function laboratories.
- To assess the necessity of additional precautions for specific patient groups.
Main Methods:
- Literature review of studies on cross-infection and lung function testing equipment.
- Analysis of disinfection and sterilization methods for respiratory equipment.
- Evaluation of factors influencing patient susceptibility and infectivity.
Main Results:
- The degree of cross-infection risk from lung function equipment is not fully quantified.
- Routine cleaning and disinfection are generally adequate; elaborate precautions are not widely justified.
- Chemical disinfection methods require careful application.
- Additional precautions like barrier filters may be needed for infectious or immunocompromised patients, but routine use is not cost-effective based on current evidence.
Conclusions:
- While the exact risk is unquantified, current evidence supports routine cleaning and disinfection for lung function equipment.
- Specific patient factors (infectious or immunocompromised status) warrant tailored precautions.
- Further research is needed to precisely quantify cross-infection risks, guiding future recommendations.